FORMULATIONS

摘要

The present invention is directed to orally deliverable dosage forms with a rapid release profile comprising 4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin- 3-yl)-(1 R)-1 -[(4-hydroxy-3,5-dimethylphenyl)methyl]-2-[4-(4-morpholinyl)- 1 -piperidinyl]-2-oxoethyl-1 -piperidinecarboxylate and/or a pharmaceutical acceptable salt thereof and a method for the production thereof.